Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
21 Oktober 2022 - 11:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month October 2022
(Commission File No. 001-35193)
Grifols, S.A.
(Translation of registrant’s name into English)
Avinguda de la Generalitat, 152-158
Parc de Negocis Can Sant Joan
Sant Cugat del Valles 08174
Barcelona, Spain
(Address of registrant’s principal executive
office)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F
x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ¨
No x
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ¨
No x
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes ¨
No x
If “Yes” is marked, indicate below the file number assigned
to the registrant in connection with Rule 12g3-2(b): 82- . .
Grifols, S.A.
TABLE OF CONTENTS
8-K
![GRAPHIC](https://content.edgar-online.com/edgar_conv_img/2022/10/21/0001104659-22-110671_tm2228707d1_6kimg001.jpg)
| Grifols, S.A.
Avinguda de la Generalitat
152
-
158
08174 Sant Cugat del Vallès
Barcelona
-
ESPAÑA
Tel
.
[34] 935 710 500
Fax
[34] 935
710 267
ww.grifols.com
Grifols, S.A. ("
Grifols
"), in accordance with the provisions of article 227 of the Consolidated
Text of the Securities Market Act, approved by the Legislative Royal Decree 4/2015, of 23
October, reports the following
OTHER RELEVANT INFORMATION
Following the
article released
ea
rlier today
in certain
Spanish
media
regarding
Grifols facing a
potential lawsuit
as a result of
a claim
for violating
Donors’
biometric identification rights
in
Illinois
(U.S.)
,
Grifols
w
ishes
to
communicate that t
his case was properly
disclosed
in
its
audited
consolidated financials for FY2021 and Half
-
Year 2022.
It should be noted that
t
he Court’s
recent
o
rder
does nothing more than allow the
plaintiffs
’ case to proceed, and therefor
e
assumes for
purposes of that order that the plainti
ffs’ allegations are true
.
However, there has not yet been any
factual determination of the validity of those
facts,
and i
t is not a final determination.
Grifols
believes that it has meritorious defenses to the plaintiffs’ claims.
Grifols has not recogniz
ed any provision for th
e
claim
in its financials
due to its lack
of
materiality
in accordance
with
the assessment performed by its legal advisors
.
In reaching this determination,
t
he company has also considered
other
similar
cases
with
in the
plasma
industry
,
a
s well as
the
insurance coverage
applicable
.
In Barcelona, on
21
October 2022
Nuria Martín Barnés
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
Grifols, S.A. |
|
|
|
|
By: |
/s/ David I. Bell |
|
|
Name: |
David I. Bell |
|
|
Title: |
Authorized Signatory |
Date: October 21, 2022
Grifols (PK) (USOTC:GIKLY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Grifols (PK) (USOTC:GIKLY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Grifols SA (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Grifols Sa News-Artikel